| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Immunome, Inc. (IMNM) has 13 insiders with recent SEC Form 4 filings, including 3 buys and 0 sells. IMNM is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Dir | 2.04M | $45.83M | - | |
| CEO | 690.7K | $15.50M | - | |
| Dir | 341.1K | $7.66M | - | |
| Other | 242.0K | $5.43M | - | |
| CFO | 207.0K | $4.65M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| May 24, 2021 | Lamattina John L | Director | Buy | 5,440 | $18.57 | $101,027.88 | +5.8% | -23.5% | -81.7% | |
| Oct 6, 2020 | Rapp Michael | Director | Buy | 83,332 | $12.00 | $999,984.00 | +15.0% | - | - |